William N Addison and Marc D McKee have subsequently responded with a Letter to the Editor available here: http://dx.doi.org/10.1002/jbmr.110.
1523-4681/asset/olbannerleft.gif?v=1&s=d7e4c0e37904a489128d3a4e58ba94214db307a9)
1523-4681/asset/olbannerright.gif?v=1&s=854ee0e4d351ead9faaca8bfab3e50b1c7c9d03d)
Commentary
You have free access to this content
ASARM mineralization hypothesis: A bridge too far?†
Article first published online: 23 FEB 2010
DOI: 10.1002/jbmr.69
Copyright © 2010 American Society for Bone and Mineral Research
Additional Information
How to Cite
David, V. and Quarles, L. D. (2010), ASARM mineralization hypothesis: A bridge too far?. J Bone Miner Res, 25: 692–694. doi: 10.1002/jbmr.69
- †
Publication History
- Issue published online: 9 APR 2010
- Article first published online: 23 FEB 2010
- Accepted manuscript online: 23 FEB 2010 12:00AM EST
References
- 1, , , et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006; 17: 1305–1315.
- 2, , , et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281: 6120–6123.
- 3, , , et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444: 770–774.
- 4. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008; 118: 3820–3828.
- 5. Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest. 2003; 112: 642–646.
- 6, , , et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 38: 1310–1315.
- 7, , , et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone. 2004; 34: 303–319.
- 8, , , , . Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J Endocrinol. 2007; 192: 261–267.
- 9, , , , , . Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006; 291: E38–E49.
- 10, , , et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 1310–1315.
- 11, , , , , . Inhibition of MEPE cleavage by Phex. Biochem Biophys Res Commun. 2002; 297: 38–45.
- 12, , , et al. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005; 36: 33–46.
- 13, , , . Phosphorylation-Dependent Inhibition of Mineralization by Osteopontin ASARM Peptides is Regulated by PHEX Cleavage. J Bone Miner Res. 2009;Direct Link:
- 14, , , , , . Intrinsic mineralization defect in Hyp mouse osteoblasts. Am J Physiol. 1998; 275: E700–E708.
- 15, , , , . MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res. 2008; 23: 1638–1649.Direct Link:
- 16, , , et al. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology. 2008; 149: 1757–1772.
- 17, , , et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41: 1199–1206.
- 18, , , et al. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol. 2005; 16: 1645–1653.
- 19, , , et al. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest. 2008; 118: 722–734.
- 20, , , , , . Aberrant Phex Function in Osteocytes Has Limited Effects on Bone Mineralization in X-Linked Hypophosphatemia (XLH). J Bone Miner Res. 2008; 23.
- 21, , , . Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology. 2009; 150: 4012–4023.
- 22, , , et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res. 1998; 13: 1101–1111.Direct Link:
- 23, , , , , . Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1998; 101: 1468–1478.
- 24, , , . Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A. 1999; 96: 8156–8160.
- 25, , , et al. MEPE's diverse effects on mineralization. Calcif Tissue Int. 2009; 86: 42–46.
- 26, , , , , . Skeletal casein kinase activity defect in the HYP mouse. Calcif Tissue Int. 1997; 61: 256–259.